BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3170123)

  • 1. A treatment for metastasis of murine ocular melanoma.
    Harning R; Szalay J
    Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1505-10. PubMed ID: 3170123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the metastasis of murine ocular melanoma by natural killer cells.
    Harning R; Koo GC; Szalay J
    Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1909-15. PubMed ID: 2777511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma.
    Harning R; Koo GC; Szalay J
    Reg Immunol; 1990; 3(2):97-102. PubMed ID: 1965137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular metastasis of in vivo and in vitro derived syngeneic murine melanoma.
    Harning R; Szalay J
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1599-604. PubMed ID: 3623843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice.
    Niederkorn JY
    Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1080-6. PubMed ID: 6381375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
    Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
    Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA
    Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
    Yang H; Xu Z; Iuvone PM; Grossniklaus HE
    Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental model for metastasis of intraocular melanoma: preventive role of natural killer cells.
    Yokoyama T; Yoshie O; Mizuno K
    Jpn J Ophthalmol; 1989; 33(1):76-84. PubMed ID: 2733256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma.
    Dithmar S; Rusciano D; Grossniklaus HE
    Melanoma Res; 2000 Feb; 10(1):2-8. PubMed ID: 10711634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
    Yang H; Akor C; Dithmar S; Grossniklaus HE
    Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis of ocular and flank implants of the 13762NF mammary adenocarcinoma in syngeneic rats.
    Szalay J; Sabzevari H
    J Natl Cancer Inst; 1987 Oct; 79(4):837-45. PubMed ID: 3477664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
    Kobayashi M; Kobayashi H; Pollard RB; Suzuki F
    J Immunol; 1998 Jun; 160(12):5869-73. PubMed ID: 9637498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.